SARS-CoV-2 spike glycoprotein modulator (Abound Bio)

N/A

Report date: 2025/01/26 15:58:30

Base Information

Drug NameSARS-CoV-2 spike glycoprotein modulator (Abound Bio)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionG-protein coupled receptor antagonists

TargetsG-protein coupled receptor

Therapy Area/IndicationsCentral Nervous System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbilita Bio Inc

China Registration ClassN/A

Active CompaniesAbilita Bio Inc

Inactive CompaniesN/A

Active IndicationsCentral Nervous System DiseasesNeoplasms

Inactive IndicationsN/A

ATC CodeN/A